Search results
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks· 2 days agoFree Report) reported adjusted earnings of $2.07 per share for first-quarter 2024, beating the Zacks Consensus Estimate of $1.94. Earnings rose 48% year over year on a reported basis and 54% ...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 1 day agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 2 days agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 1 day agoSales of human papillomavirus vaccine Gardasil jumped 14% to $2.25 billion. That narrowly topped...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 2 days agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
20 Fastest Growing Health Tech Companies in the World
Insider Monkey via Yahoo Finance· 2 days agoIn this article, we will be taking a look at the 20 fastest growing health tech companies in the...
How Many More Ozempic-like Drugs Are In the Pipeline — Here’s What Researchers Are Working On
Inverse· 6 days agoFew drugs have achieved the stardom that semaglutide, marketed in the United States as Ozempic or...
Will Higher Keytruda Sales Drive Merck's Q1
Forbes· 3 days agoMerck (NYSE: MRK) will report its Q1 2024 results on Thursday, April 25. As usual, Keytruda will be the driving growth for Merck with quarterly sales...
Sigma Planning Corp Sells 25,974 Shares of Merck & Co., Inc. (NYSE:MRK)
ETF DAILY NEWS· 5 days agoSigma Planning Corp reduced its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 56.2% during the 4th quarter, according to the company in its most recent Form 13F filing with ...
Q3 2024 Earnings Forecast for Merck & Co., Inc. Issued By Leerink Partnrs (NYSE:MRK)
ETF DAILY NEWS· 5 days agoMerck & Co., Inc. (NYSE:MRK – Free Report) – Research analysts at Leerink Partnrs raised their Q3 2024 earnings per share estimates for Merck & Co., Inc. in a report released on Friday, April ...